Fidelity International’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-31,200	Closed	-$1.98M	–	600
2013 Q3	$1.98M	Sell	31,200 -17,200	-36%	-$1.09M	0.01%	449
2013 Q2	$2.03M	Buy	+48,400	New	+$2.03M	0.01%	405